Consequently, further scRNA-seq analysis of BCC resistant to vismodegib revealed that LYPD3, TACSTD2 (also known as TROP-2), and LY6D were significantly overexpressed in cells with high MRTF expression. The gene discussed is TACSTD2; the disease is skin basal cell carcinoma.